{
    "title": "GlaxoSmithKline's full-year results another test for embattled boss Emma Walmsley as she continues to fend off attacks from activist investor Elliott",
    "url": "https://www.dailymail.co.uk/money/share-investing/article-10477917/GlaxoSmithKlines-results-test-boss-Emma-Walmsley.html",
    "date": "2022-02-04",
    "keywords": [
        "share",
        "investor",
        "elliott",
        "price",
        "gsk",
        "focus",
        "wednesday",
        "test",
        "executive",
        "emma",
        "walmsley",
        "management",
        "company",
        "pressure",
        "demerger",
        "consumer",
        "healthcare",
        "business",
        "swoop",
        "division",
        "month",
        "push",
        "rise",
        "space",
        "strategy",
        "stock",
        "outlook",
        "guidance",
        "october",
        "decline",
        "brummer",
        "fish",
        "bid",
        "scientist",
        "astrazeneca",
        "victory",
        "lab",
        "study",
        "article",
        "money",
        "data",
        "dividend",
        "year",
        "sharemeanwhile",
        "medicine",
        "pipeline",
        "attention",
        "hiv",
        "cancer",
        "progress"
    ],
    "category": [
        "money"
    ]
}